Drug Profile
Research programme: topoisomerase I inhibitors - deCODE genetics
Alternative Names: Topoisomerase I inhibitors research programme - deCODE geneticsLatest Information Update: 15 Sep 2006
Price :
$50
*
At a glance
- Originator deCODE genetics
- Class
- Mechanism of Action DNA topoisomerase I inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 15 Apr 2002 MediChem Life Sciences has been acquired by deCODE genetics
- 15 Nov 2001 New profile
- 15 Nov 2001 Preclinical development for Cancer in USA (Unknown route)